Prodia Diagnostic Line Tbk is trading 34.6% up at $218 as the stock continues to benefit from significant post-IPO momentum and follow-through buying.
- The stock reportedly hit the IDX upper auto-reject limit of 35% (Rp162) during its debut, signaling heavy investor demand for the new issue.
- The current price action appears driven by listing enthusiasm, as no separate major company announcements were found for July 13.